The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Jun. 29, 2018
Applicants:

Royal Melbourne Institute of Technology, Melbourne, AU;

University of South Australia, South Australia, AU;

The Provost, Fellows, Foundation Scholars, and the Other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth, Near Dublin, Dublin, IE;

Monash University, Clayton, AU;

Inventors:

Stavros Selemidis, Forest Hill, AU;

Doug A. Brooks, Cheltenham, AU;

John O'Leary, Enniskerry, IE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); A61K 38/00 (2006.01); A61P 37/00 (2006.01); A61P 31/00 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61P 29/00 (2018.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07K 14/70596 (2013.01); A61K 38/00 (2013.01); C07K 2319/10 (2013.01);
Abstract

The present invention relates generally to the field of immunomodulation. Taught herein is an agent for inhibiting immunostimulation mediated by a Toll-like receptor useful in the treatment of viral and microbial pathogenesis, diseases involving elements of autoimmunity and inflammation as well as cancer. The agent antagonizes disulfide bond formation between C98 and C475 of Toll-like receptor 7 (TLR7) thereby preventing TLR7 activation. Pharmaceutical compositions are also enabled herein.


Find Patent Forward Citations

Loading…